United Health Products, INC S-1 registration statements
Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.
OQB
United Health Products, Inc. is navigating significant FDA regulatory challenges for its CelluSTAT hemostatic gauze while securing up to $4 million in new financing from Alumni Capital LP.
OQB
United Health Products, Inc. files an amendment to its S-1 registration statement to include a new exhibit related to accounting firm consent.
OQB
United Health Products seeks to register 15 million shares for resale by White Lion Capital as it awaits FDA decision on its hemostatic gauze product.
OQB
United Health Products registers 15 million shares for resale by White Lion Capital under existing purchase agreement.
OQB
United Health Products seeks to register the resale of 15 million common shares by White Lion Capital, aiming to fulfill obligations under their Common Stock Purchase Agreement.